Jun-cheng Wang - Sun Yat-Sen University Cancer Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 92 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Stereotactic Body Radiotherapy is an Alternative to Radiofrequency Ablation for Single HCC ≤ 5.0 Cm

Zhoutian Yang,Shiliang Liu, Li Hu,Jinbin Chen,Juncheng Wang,Yangxun Pan,Li Xu,Mengzhong Liu,Minshan Chen,Mian Xi,Yaojun Zhang

JHEP REPORTSno. 10 (2024)

引用0浏览0WOS引用

Mirnome Targeting NF-κB Signaling Orchestrates Macrophage-Triggered Cancer Metastasis and Recurrence

Dong-Ping Chen,Jun-Cheng Wang,Zheng-Yu Liu, Pei-Lin Li,Ka-Wo Chan,Xiang-Ning Wu, Wu-De-Xin Yao,Tingting Yao,Dong-Ming Kuang,Yuan Wei

MOLECULAR THERAPYno. 4 (2024): 1110-1124

引用0浏览0WOS引用

YTHDF2 in Peritumoral Hepatocytes Mediates Chemotherapy-Induced Antitumor Immune Responses Through CX3CL1-mediated CD8+ T Cell Recruitment

Zhenyun Yang,Xin Wang,Yizhen Fu,Weijie Wu,Zili Hu, Qingyang Lin, Wei Peng,Yangxun Pan,Juncheng Wang,Jinbin Chen,Dandan Hu,Zhongguo Zhou,Li Xu,Yaojun Zhang,Jiajie Hou,Minshan Chen

Molecular Cancerno. 1 (2024): 1-20

引用0浏览0WOS引用

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma after Hepatic Arterial Infusion Chemotherapy

Wenxuan Li,Zhikai Zheng,Jiongliang Wang,Tianqing Wu,Juncheng Wang,Yangxun Pan,Jinbin Chen,Dandan Hu,Li Xu,Yaojun Zhang,Minshan Chen,Zhongguo Zhou

JOURNAL OF HEPATOCELLULAR CARCINOMA（2024）

引用0浏览0WOS引用

The Emerging Therapies Are Reshaping the First-Line Treatment for Advanced Hepatocellular Carcinoma: a Systematic Review and Network Meta-Analysis

Wei Peng,Yangxun Pan, Lan Xie,Zhoutian Yang,Zhiwei Ye,Jinbin Chen,Juncheng Wang,Dandan Hu,Li Xu,Zhongguo Zhou,Minshan Chen,Aiping Fang,Yaojun Zhang

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2024)

引用0浏览0WOS引用

Elucidate the Role of PERP on the Prognosis of Head and Neck Squamous Cell Carcinoma by Regulating Immune Microenvironment and Metabolic Homeostasis

Xueying Wang,Huihong chen, Yewen Zhu, Zhaoyu Pan, Jiaoyan Cao, Zhenjiang Li,Yuxi Tian, Diab Mohammed,Xin Zhang,Yong Liu,Juncheng Wang

crossref（2024）

引用0浏览0引用

Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study

Wei Wang,Ruixia Li,Hui Li,Murong Wang,Juncheng Wang,Xiaohui Wang,Qunfang Zhou

IMMUNOTARGETS AND THERAPY (2024): 399-412

引用0浏览0WOS引用

Cholesterol and C-reactive Protein Prognostic Score Predicted Prognosis of Immune Checkpoint Inhibitors Based Interventional Therapies for Intermediate-to-advanced Hepatocellular Carcinoma Patients

Huilan Zeng,Deyao Zhang,Zhenyun Yang,Zili Hu,Zhoutian Yang,Yizhen Fu,Jingyu Hou, Siegmund Ngai,Juncheng Wang,Jinbin Chen,Dandan Hu,Zhongguo Zhou,Minshan Chen,Yaojun Zhang,Yangxun Pan

International Immunopharmacology (2023): 109651-109651

引用1浏览0WOS引用

Supplementary Methods from Polarization of Tissue-Resident T<sub>FH</sub>-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization

Minmin Chen, Xiao,Xiang-Ming Lao, Yuan Wang, Ruixian Liu,Qiu-Hui Zeng,Juncheng Wang,Fang-Zhu Ouyang,Dongping Chen,Ka-Wo Chan,Dai-Chao Shi,Li‐Min Zheng,Dong-Ming Kuang

openalex（2023）

引用0浏览0引用

Comparison of Hepatic Arterial Infusion Chemotherapy with Mfolfox Vs. First-Line Systemic Chemotherapy in Patients with Unresectable Intrahepatic Cholangiocarcinoma

Zhenyun Yang,Yizhen Fu,Weijie Wu,Zili Hu,Yangxun Pan,Juncheng Wang,Jinbin Chen,Dandan Hu,Zhongguo Zhou,Minshan Chen,Yaojun Zhang

Frontiers in pharmacology (2023)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn